randomized and placebo-controlled studies on the possible relationship between vitamin D and respiratory infections of nearly 49,000 participants. (Danielle Masterson 2021. In a study of 212 patients with Covi-19 of those who had severe disease, 96% had low vitamin D levels, while 96% of those with mid-level disease had higher levels of vitamin D. Other compounds also demonstrated efficacy, first by offering protection against the Covi-19, and as an adjuvant treatment in hospitals to increase the rate of recovery and decrease mortality.
According to Geert Vandeen Bossche and Dr. Surcharit Bhakdi, the Covi-19 has a high capacity for mutation. If you put living organisms like bacteria or viruses under pressure, via antibiotics, but you don’t kill them off completely, you encourage them to mutate into more virulent strains. Those that escape the immune system end up mutating to ensure their further survival. Also even if the vaccine kills many viruses others survive and will reactivate in the future, causing more severe disease.
Mass covid-19 vaccination could be similar to the uses of antibiotics by resistant bacteria. Antibiotics are increasingly losing their effectiveness against common bacteria as we know today. Hence, we now face super-bacteria that can kill.
Another example is the use of chemotherapy to kill cancer cells. Many cancer cells do not die. They develop mutation through selection, become more resistant to where chemotherapy cannot kill them anymore. The more chemotherapy you do the more aggressive such cancer cells become that turn into a CSC-like state.
Figure 1: This scanning electron microscope image shows SARS- CoV-2 (Round gold objects) emerging from the surface of cells cultured in the lab. This is the virus that causes COVID-19.